Women who are vaccinated against human papillomavirus (HPV) are more likely to undergo cervical cancer screenings than unvaccinated women, according to new research by Penn State College of Medicine.
Related topics: Cancer, Oncology, Medical Research
The rate of cervical cancer among women living in neighborhoods with the lowest socioeconomic indices is nearly two times higher than the rate among those who live in areas with the highest indices.
Related topics: Cancer, Oncology
Recognizing Sylvester Comprehensive Cancer Center's enduring commitment to addressing the inequities that perpetuate cervical cancer in South Florida and beyond, the World Health Organization (WHO) on Wednesday designated the University of Miami...
Related topics: Cancer, Oncology, Medical Research
With more than 300,000 women dying from cervical cancer each year, the World Health Organization (WHO) is joining advocates from across the globe on Wednesday to commemorate a Day of Action against the disease.
Related topics: Cancer, Oncology
After decades of research, the UK implemented a human papillomavirus (HPV) vaccine programme for teenage girls in 2008. Now, for the first time, a study has shown that the UK HPV vaccine programme works and will save lives, according to research...
Related topics: Vaccines, Cancer, Oncology, Medical Research
(MedPage Today) -- CHICAGO -- Prophylactic extended-field irradiation (EFI) for locally advanced cervical cancer significantly improved overall survival (OS), disease-free survival (DFS), and extrapelvic disease control, a retrospective study...
Related topics: Cancer, Oncology, Medical Research
This article was originally published in 2017 during Cervical Screening Awareness Week. It has now been reviewed and updated. Cervical screening, also known as the smear test, isn’t actually a test for cancer. Although it does sometimes find...
Related topics: Cancer, Oncology
International collaboration involving NCCN and Polish oncology officials publishes first of several evidence-based expert consensus guidelines with latest cancer treatment recommendations, adapted for regional needs, beginning with cervical cancer.
Related topics: Cancer, Oncology
(MedPage Today) -- In vitro maturation of immature eggs may be an effective method of fertility preservation for patients with gynecologic cancers, according to a prospective observational study.
In a cohort of 76 women with ovarian, cervical...
Related topics: Fertility, Cancer, Ovarian Cancer, Oncology, Medical Research
The FDA has also approved pembrolizumab alone for patients with recurrent or metastatic cervical cancer. FDA Approvals
Related topics: Food And Drug Administration, Chemotherapy, Cancer, Oncology
For the past seven decades, the cells of Henrietta Lacks, a Black American woman who died of cervical cancer, have saved countless lives, and made numerous scientific breakthroughs possible, such as the human papillomavirus and polio...
Related topics: Medical Research, Cancer, Oncology, Vaccines
(MedPage Today) -- Patients at community oncology centers had high expectations for genomic tumor testing in association with limited understanding of how the tests work. (JCO Precision Oncology)
A doctor who spent a year hoping to make a...
Related topics: Cancer, Esophageal Cancer, Genomics, Genetics, Oncology, Lawsuits
Latina and Vietnamese women are disproportionately impacted by cervical cancer-causing human papillomavirus (HPV), a common but preventable viral infection of the reproductive tract. In addition to facing a greater burden of disease, Latina and...
Related topics: Medical Research, Cancer, Oncology
(MedPage Today) -- Will the human papillomavirus (HPV) vaccine achieve the goal of eliminating cervical cancer? (Cancer Research Catalyst)
Single-agent pembrolizumab (Keytruda) significantly improved overall survival in a randomized trial of Asian...
Related topics: Breast Cancer, Cancer, Oncology, Vaccines, Medical Research
Scientists have created a new test to measure antibodies in girls who have received a vaccine for human papilloma virus (HPV), the leading cause of cervical cancer in women. This new test and a second study establishing accurate reference intervals...
Related topics: Medical Research, Vaccines, Virus, Virology, Cancer, Oncology
Seagen Inc. SGEN, along with its Danish partner Genmab A/S GMAB, announced that the FDA has granted accelerated approval to their investigational antibody drug conjugate (“ADC”), Tivdak (tisotumab vedotin-tftv), for the treatment of...
Related topics: Food And Drug Administration, Cancer, Oncology
(MedPage Today) -- The FDA granted accelerated approval to tisotumab vedotin-tftv (Tivdak), a first-in-class drug, for the treatment of patients with recurrent or metastatic cervical cancer, drugmakers Seagen and Genmab announced.
Tisotumab...
Related topics: Food And Drug Administration, Cancer, Oncology
(MedPage Today) -- Adding pembrolizumab (Keytruda) to chemotherapy with or without bevacizumab (Avastin) significantly slowed progression of metastatic cervical cancer and improved overall survival (OS), investigators in a randomized trial...
Related topics: Medical Research, Cancer, Oncology, Chemotherapy, Avastin
MONDAY, Aug. 9, 2021 -- Global cervical cancer incidence and mortality rates have remained stable or are decreasing, according to a study published online Aug. 9 in Cancer.
Shujuan Lin, from Zhejiang University School of Medicine in Hangzhou,...
Related topics: Cancer, Oncology, Medical Research
On Saturday, August 14, 2021, qualified women who make an appointment can receive free cervical and breast cancer screenings as part of Loyola Medicine's 6th annual See, Test and Treat(r) event. See, Test and Treat(r) will be held at the Loyola...
Related topics: Breast Cancer, Cancer, Oncology